HeartBeam, Inc. (BEAT) Research

HeartBeam, Inc. is a medical technology firm specializing in remote cardiac care. The company provides telemedicine solutions designed to diagnose and monitor heart conditions outside of traditional healthcare facilities. Their offerings empower physicians with vital diagnostic data, enabling effective management of patients with cardiovascular disease. At the core of their telehealth product is a compact, credit card-sized electrocardiogram (ECG) device, seamlessly integrated with a cloud-based diagnostic software platform. This innovative system addresses the rapidly expanding need for remote patient monitoring. HeartBeam, Inc. was established in 2015 and is headquartered in Santa Clara, California.

Market snapshot

Symbol
BEAT
Price
$0.76
Day change
+6.03%
Market cap
$26.2M
P/E ratio
-1.52x
52-week range
0.54-4
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months
Analyst price target
$6.25

Peer companies

  • CervoMed Inc. (CRVO)
  • Equillium, Inc. (EQ)
  • Werewolf Therapeutics, Inc. (HOWL)
  • MiNK Therapeutics, Inc. (INKT)
  • IO Biotech, Inc. (IOBT)
  • Spectral AI, Inc. (MDAI)
  • OneMedNet Corporation (ONMD)
  • OS Therapies Incorporated (OSTX)

Recent insider activity

  • Ferrari Richard — P-Purchase (57500 shares) on 2026-04-16
  • Cruickshank Tim — P-Purchase (31250 shares) on 2026-04-16
  • Elfrink Willem — P-Purchase (187500 shares) on 2026-04-16
  • JAFF MICHAEL R — P-Purchase (31250 shares) on 2026-04-16
  • Vajdic Branislav — P-Purchase (31250 shares) on 2026-04-16

Open HeartBeam, Inc. (BEAT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.